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Post-Therapeutic Thyroid Reserve 
Thyro id Reserve in Euthyro id Patients 
A f t e r A b l a t i v e Therapy for Di f fuse Toxic Goi ter 
J. Joseph Prendergast, M . D . * and J. M a r t i n M i l l e r , M . D . * * 
Thyroid reserve was measured in 41 patients who were euthyroid 5 to 15 years after 
therapy for diffuse toxic goiter. Twenty-one of them had been treated by "7. 20 by 
surgery and 10 were normal controls. All had a PBI (protein bound iodine) 
and 3-hour thyroidal ''"I uptake. The same parameters of function were measured 
again 24 hours after they were given 10 units of thyroid stimulating hormone (TSH) 
intramuscularly. Only two patients in each treatment group responded with normal 
elevation of both the PBI and "7 uptake. In 52% of the '"I-ti-eated padents and in 
55% of those surgically treated there was no significant increase in either PBI 
or thyroidal iodine uptake. These results suggest that current efforts to reduce the 
early post "'I incidence of hypothyroidism may result in a long-term reduction of 
this complication as well and make this group comparable to those treated 
surgically. It is certain, however, that no patient receiving either therapy should 
be dismissed from continuing medical followup. 
There are few documented reports 
of untreated patients with diffuse toxic 
goiter, but it has been known since 
1888 that the natural course of Graves' 
disease for some patients leads to hypo-
thyroidism.Because this has become 
more common as a result of ablative 
therapy for diffuse toxic goiter, the 
prevention of post-therapy hypothy-
roidism is a major problem. Recent 
studies have demonstrated an increas-
ing incidence of hypothyroidism with 
each subsequent year after therapy. A 
*Now at the Univ. of California, San 
Francisco 
•••*Division of Endocrinology 
somewhat lower incidence per year has 
been reported for patients who have 
undergone subtotal thyroidectomy^" 
than for those treated with ^ ^ ^ I . 
Months or years following the sur-
gical or radioiodine therapy of Graves' 
disease the abnormal stimulator of the 
thyroid gland may disappear and the 
normal hypothalamic pituitary thyroid 
relationships return. Theoretically it is 
then possible to detect the functional 
capacity of the thyroid remnant which 
is in excess of that necessary for main-
taining the euthyroid state. The con-
cept and significance of "thyroid re-
serve" was first described by Jefferies 
et al.^° He described the response of 
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both the protein bound iodine (PBI) 
and the radioiodine uptake to a stan-
dard dose of thyroid stimulating hor-
mone (TSH) and noted that either in-
dex of response could be abnormally 
low in a euthyroid patient. The present 
study was designed to determine the 
degree of such responses in patients 
who were euthyroid at least five years 
after therapy for diffuse toxic goiter. 
All euthyroid patients available for 
restudy were included. No attempt was 
made to compare the incidence of 
hypothyroidism occurring after the two 
modes of therapy, since our interest 
was in determining the behavior of the 
thyroid remnant surviving either treat-
ment. 
Methods 
Thyroid reserve as described by Jef-
feries" was measured in 41 euthyroid 
subjects, 5 to 15 years after therapy 
for hyperthyroidism, and in 10 "con-
trols." Of the first group, 21 had re-
ceived between 2.5 and 30.0 mc of 
'•'T and 20 had undergone subtotal 
thyroidectomy as definitive therapy for 
their diffuse toxic goiter. 
The diagnosis of Graves' disease 
prior to therapy was initially estab-
lished on a clinical basis and was sup-
ported by determination of the basal 
metabolic rate (BMR), PBI or 24-hour 
' • " I uptake. Excluded from this study 
were all patients with hyperthyroidism 
caused by a single hyperfunctioning 
nodule or a long standing muhinodular 
goiter, and those who had received both 
surgery and therapy. 
The control group (data shown in 
Table I ) was made up of volunteers 
judged to be euthyroid by clinical 
examination. They had normal PBI 
responses, no familial history of thyroid 
disease and no thyroid enlargement. 
Each was examined by one of the 
authors and the PBI was obtained to 
confirm the clinical impression. 
Each was given 10 pc of i - " I by 
mouth and the uptake was measured 
three hours later. Ten units of TSH 
(Thytropar, Armour) were then given 
by intramuscular injection. The ' - " I 
uptake was measured 24 hours prior 
to the administration of a second 10 
pC for determination of the stimulated 
three-hour uptake. Blood for a PBI 
was drawn at the end of the second 
three-hour uptake. Thus both an index 
of hormone release'- " and of hor-
monal synthesis'"' after TSH were 
measured. The normal PBI in our lab-
oratory ranges between 4.0 and 8.0 
iJig%. The normal three-hour uptake 
is between 5% and 15%. 
Results 
An increase of 1 pg% of PBI and 
a 5% result in the three-hour uptake 
represented a significant response, as 
measured in our controls and by the 
studies of Jefferies.'" All controls 
(Table I ) had at least that great a 
response, with a range of increase from 
1.1 to 3.3 pg% of PBI and from 
8.9% to 15.0% in uptake. 
Table I I represents the data from 
the '-'T-treated patients and Table I I I 
contains the results in the surgically 
treated patients. Average age was 38.9 
years for surgical patients and 52.4 
years for those treated with the '^T. 
The time elapsed since therapy aver-
aged nine years for the surgical group 
and 9.3 years for the irradiated group. 
The higher-than-normal PBI in surgical 
patient #18 was related to increased 
thyroxine binding globulin from an 
oral contraceptive. It is, therefore, not 
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TABLE I 
CONTROL 
3 Hour Uptake (%) Serum PBI (meg %) 
Before After Before After 
No. Age Sex TSH TSH Change TSH TSH Change 
1 39 F 6.8 20.6 13.8 4.6 7.0 2.4 
2 54 F 7.9 19.1 n.2 4.7 7.7 3.0 
3 49 F 17.6 32.6 15.0 5.8 8.8 3.0 
4 41 M 9.1 18.5 9.4 4.1 5.5 1.4 
5 36 F 7.1 19.0 1L9 4.1 6.0 L9 
6 66 M 3.4 17.5 14.1 4.7 6.0 L3 
7 35 F 12.3 22.2 9.9 4.5 7.8 3.3 
8 40 F n.3 21.6 10.3 5.4 6.9 L5 
9 20 F 12.9 23.9 U.O 5.1 6.4 L3 
10 19 F 8.0 16.9 8.9 4.7 5.8 U 
10* 10* 
* Number of patients with a significant increase 
a true measurement of thyroid func-
tion.i*' 
A significant increase in both para-
meters of thyroid function after TSH 
appeared in only two patients out of 
the 21 tested in the '^T treated group. 
In 11 patients (52% ) , neither the PBI 
nor the uptake responded significantly. 
The group of eight patients in which 
only the uptake was significantly ele-
vated is believed to represent those 
with additional secretory capacity but 
with low hormone storage. 
In the group of 20 patients who un-
derwent subtotal thyroidectomy only 
two responded normally. Again, 11 
(55%) exhibited no significant re-
sponse in either measurement. Only 
four of the surgically treated patients 
responded to TSH with increase of the 
uptake, while this result occurred in 
10 of the "ij.treated group. On the 
other hand, only two of the irradiated 
group responded with elevated PBI, 
while in the surgically treated, seven 
patients were found responsive. These 
differences are of questionable statisti-
cal difference. 
In both groups, some patients ex-
hibited a greater drop in the iodine 
uptake after TSH stimulation than 
could be expected from the inherent 
error of the measurement. This ob-
servation may be explained by a drop 
in the background count during the 
second three-hour uptake. The accel-
erated turnover of " ' I in the thyroid 
remnant after stimulation by TSH 
could produce this variation. The PBI 
also decreased in several cases in both 
groups, but values were within the 
error of reproducibility of the method. 
Discussion 
The use of thyrotropin in the study 
of the pathophysiology of the thyroid 
gland was suggested over 30 years ago. 
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TABLE 1! 
131-1 Treated 
3 Hour Uptake (%) Serum PBI (meg %) 
Age Years 
When Since 
No. Studied Sex Therapy 
Before After 
TSH TSH 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
57 
49 
53 
47 
62 
52 
55 
42 
46 
52 
56 
73 
49 
41 
56 
39 
59 
66 
57 
38 
50 
M 
M 
5.6 
9.3 
10.2 
11.2 
9.7 
9.0 
9.1 
9.0 
9.7 
8.8 
10.4 
9.3 
11.4 
9.6 
8.5 
9.4 
9.2 
12.8 
7.8 
8.0 
7.8 
5.7 
9.7 
13.7 
10.5 
7.9 
13.7 
8.0 
12.0 
10.7 
11.6 
9.7 
12.3 
14.4 
8.4 
13.6 
3.4 
8.6 
13.1 
6.1 
9.2 
9.0 
46.0 
7.4 
11.0 
17.8 
12.5 
14.0 
10.6 
20.0 
24.9 
24.9 
9.6 
27.0 
11.6 
10.1 
19.4 
7.8 
16.3 
6.2 
14.0 
17.9 
9.0 
Change 
40.3 
-2.3 
-2.7 
7.5 
4.6 
.3 
2.6 
8.0 
14.2 
13.3 
-.1 
14.1 
-2.8 
1.7 
5.8 
4.4 
7.7 
-6.9 
5.9 
8.7 
g_ 
10* 
Before 
TSH 
4.2 
3.0 
3.9 
4.3 
4.4 
5.5 
4.0 
4.4 
4.6 
5.3 
3.8 
5.1 
4.8 
5.1 
6.0 
3.4 
5.7 
5.1 
5.0 
6.4 
5.8 
After 
TSH 
5.5 
3.5 
4.1 
4.2 
4.8 
5.5 
3.9 
4.0 
5.3 
4.9 
3.5 
6.2 
5.0 
4.8 
6.0 
3.6 
6.1 
4.5 
4.3 
6.0 
5.7 
Change 
1.3 
.5 
.2 
-.1 
.4 
0 
-.1 
-.4 
.7 
-.4 
-.3 
1.1 
.2 
-.3 
0 
.2 
.4 
-.6 
-.7 
-.4 
- .1 
2* 
Number of patients with significant increases 
The intramuscular injection of TSH 
induces an increased avidity for iodine 
and a discharge of hormones from the 
gland." As Jefferies emphasized and 
our data show, both properties should 
be measured when estimating thyroid 
reserve, since they may vary inde-
pendently. 
"Normal thyroid reserve" in treated 
patients implies that despite partial 
destruction of the gland the thyroid 
may continue to function normally. 
"Low reserve" suggests that some de-
gree of hypothyroidism may be im-
minent. However, no prospective data 
have yet been obtained to confirm this 
speculation. 
In our study thyroid reserve was 
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studied in patients with Graves' disease 
who had been returned to the euthyroid 
state either by surgery or radioactive 
iodine therapy. More than half the 
patients in both groups exhibited low 
thyroid reserve. This failure to respond 
to injected TSH indicates that the 
thyroid remnant was receiving maxi-
mal stimulation from an endogenous 
thyroid stimulator. Since no suppres-
sion tests nor assays for TSH or long 
acting thyroid stimulator (LATS) 
were obtained, we have no evidence 
whether the gland was responding to 
TSH or to the persistant autonomous 
stimulator of Graves' disease. 
In 1955 Martin and Stanbury meas-
ured the response of the ^^'I-treated 
thyroid gland to exogenous TSH eight 
months or more after therapy, Two 
of their 12 patients had also under-
gone subtotal thyroidectomy prior to 
i ^ ' I therapy and were hypothyroid 
when tested. Four of ten euthyroid 
TABLE III 
Surgically Treated 
3 Hour Uptake (%) Serum PBI (mcq %) 
Na 
1 
Age 
When 
Studied 
42 
Sex 
Years 
Since 
Therapy 
5.9 
Before 
TSH 
8.2 
After 
TSH 
21.3 
Change 
13.1 
Before 
TSH 
5.2 
After 
TSH 
5.5 
Change 
.3 
2 24 F 5.7 9.6 4.0 -5.6 4.5 5.3 .8 
3 35 F 5.4 13.9 16.6 2.7 5.7 6.6 .9 
4 32 M 5.7 7.2 10.0 2.8 4.2 4.7 .5 
5 53 F 10.6 6.4 12.2 5.8 5.2 7.1 1.9 
6 54 F 6.6 6.0 12.0 6.0 5.8 5.8 0 
7 39 M 10.0 10.3 11.0 .7 3.4 3.7 .3 
8 31 F 7.3 9.9 18.2 8.3 5.2 6.9 1.7 
9 42 F 7.5 9.4 10.0 .6 6.3 7.5 1.2 
10 28 F 11.5 7.5 10.6 3.1 4.6 4.7 .1 
11 37 M 10.7 7.2 7.4 .2 4.1 4.3 .2 
12 40 F 10.1 10.0 13.6 3.6 5.0 4.8 -.2 
13 40 F 11.1 10.1 10.3 .2 5.1 5.9 .8 
14 30 F 10.4 10.5 12.3 1.8 6.5 7.3 .8 
15 41 M 13.2 6.5 10.0 3.5 4.3 4.8 .5 
16 34 F 5.7 9.6 12.4 2.8 6.3 7.9 1.6 
17 52 6.9 19.3 17.0 -2.3 5.8 6.0 .2 
18 52 F 10.0 14.1 6.0 -8.1 10.0 11.0 1.0 
19 22 F 11.3 10.3 10.0 - .3 6.1 7.7 1.6 
20 41 13.0 9.7 11.8 2.1 
4* 
5.3 6.6 1.3 
7* 
Number of patients with significant increase 
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subjects had no significant response 
in either uptake or PBI, four patients 
had normal thyroid reserve as indicated 
by both measurements, while of the 
remaining two a significant increase in 
the PBI occurred in one and the up-
take rose in the other. 
The present study compares thyroid 
reserve after a considerably longer 
time following '-'T therapy and surgery. 
Martin and Stanbury's data indicate 
somewhat better thyroid function in 
the early months following treatment 
as compared to the reserve 5 to 15 
years after therapy. However, Bronsky 
et al"* have recently pointed out the 
statistical limitations of many studies 
implicating irradiation as an important 
factor in the late occurrence of hypo-
thyroidism in Graves' disease. 
Recent studies in rats have demon-
strated inhibition of DNA synthesis in 
'•"I-irradiated glands and a shorter 
life span for these same cells.'^ Pre-
sumably the shortened individual cell 
life span as well as the impaired ability 
to proliferate accounts for the increas-
ing hypothyroidism which appears to 
occur with timc-^-^i The reproducing 
capacity of thyroid cells may also be 
impaired by external irradiation; and 
a high mitotic index at the time of 
irradiation as in hyperthyroidism, pre-
sumably makes the cells more vulner-
able. In attempts to decrease the in-
cidence of hypothyroidism, pre-treat-
ment with antithyroid drugs renders 
the thyroid cell relatively radioresistant 
correlated with decreased mitotic ac-
tivity.-- From present reports, little 
advantage seems to have been gained 
by this approach.-''' In fact, there is 
evidence to suggest that such treatment 
may have a carcinogenic effect in 
rats.-* 
One suggested approach is to de-
crease the total quantity of radiation, 
administering as little as one-half the 
present usual treatment dose. The pa-
tient may be maintained with iodine 
or antithyroid drugs until he becomes 
euthyroid.-'-2' Although the available 
followup does not permit conclusions, 
this method seems to offer some pro-
tection against hypothyroidism. The 
disadvantage of prolonging the hyper-
thyroid state with this system of ther-
apy may more than outweigh the ad-
vantage of possible preservation of 
adequate thyroid function. 
Even with the heavier dosage sched-
ules, comparison between the two 
groups in our study show no functional 
difference after 5 to 15 years between 
the non-irritated and the sublethally 
irradiated follicles. From these obser-
vations we consider hypothyroidism 
occurring after five years to be related 
to the natural history of the disease 
and not the mode of therapy although 
latent radiation effects on cellular di-
vision could still become manifest. 
However, since hypothyroidism is 
known to occur as late complication 
of untreated Graves' disease, we may 
become more aware of this aspect of 
the natural history of the disease with 
the increased life expectancy and more 
precise means of study. 
Treatment of diffuse toxic goiter by 
subtotal destruction of the thyroid re-
quires at least temporary loss of thy-
roid reserve or remission does not take 
place. Only half of the patients in 
either group had any recovery of meas-
urable reserve. This observation under-
lines the importance of close followup 
and continued medical supervision of 
all patients with Graves' disease re-
gardless of the type of therapy. 
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